Bilateral Wilms' tumor in a child with Denys-Drash syndrome: novel frameshift variant disrupts the WT1 nuclear location signaling region

J Pediatr Endocrinol Metab. 2022 Mar 21;35(6):837-843. doi: 10.1515/jpem-2021-0673. Print 2022 Jun 27.

Abstract

Objectives: Wilm's Tumor (WT) is the most common pediatric kidney cancer. Whereas most WTs are isolated, approximately 5% are associated with syndromes such as Denys-Drash (DDS), characterized by early onset nephropathy, disorders of sex development and predisposition to WT.

Case presentation: A 46,XY patient presenting with bilateral WT and genital ambiguity without nephropathy was heterozygous for the novel c.851_854dup variant in WT1 gene sequence. This variant affects the protein generating the frameshift p.(Ser285Argfs*14) that disrupts a nuclear localization signal (NLS) region.

Conclusions: This molecular finding is compatible with the severe scenario regarding the Wilm's tumor presented by the patient even though nephropathy was absent.

Keywords: Denys-Drash syndrome; WT1 nuclear localization signal; bilateral Wilms tumor.

Publication types

  • Case Reports

MeSH terms

  • Child
  • Denys-Drash Syndrome* / genetics
  • Denys-Drash Syndrome* / pathology
  • Genes, Wilms Tumor
  • Heterozygote
  • Humans
  • Kidney Neoplasms* / genetics
  • WT1 Proteins / genetics
  • Wilms Tumor* / genetics

Substances

  • WT1 Proteins
  • WT1 protein, human